PT - JOURNAL ARTICLE AU - Rebecca M. Craft AU - Alexa A. Wakley AU - Kimberly T. Tsutsui AU - Jillian D. Laggart TI - Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ<sup>9</sup>-Tetrahydrocannabinol and CP55,940 in the Rat AID - 10.1124/jpet.111.188540 DP - 2012 Mar 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 787--800 VI - 340 IP - 3 4099 - http://jpet.aspetjournals.org/content/340/3/787.short 4100 - http://jpet.aspetjournals.org/content/340/3/787.full SO - J Pharmacol Exp Ther2012 Mar 01; 340 AB - The purpose of this study was to determine whether sex differences in cannabinoid (CB)-induced antinociception and motoric effects can be attributed to differential activation of CB1 or CB2 receptors. Rats were injected intraperitoneally with vehicle, rimonabant [5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide (SR141716A), a putative CB1 receptor-selective antagonist; 0.1–10 mg/kg ] or 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528) (a putative CB2 receptor-selective antagonist; 1.0–10 mg/kg). Thirty minutes later, Δ9-tetrahydrocannabinol (THC; 1.25–40 mg/kg) or 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol (CP55,940) (0.05–1.6 mg/kg) was injected. Paw pressure and tail withdrawal antinociception, locomotor activity, and catalepsy were measured. Rimonabant dose-dependently antagonized THC and CP55,940 in each test, but was up to 10 times more potent in female than male rats on the nociceptive tests; estimates of rimonabant affinity (apparent pKB) for the CB1 receptor were approximately 0.5 to 1 mol/kg higher in female than male rats. SR144528 partially antagonized THC-induced tail withdrawal antinociception and locomotor activity in females, but this antagonism was not dose-dependent or consistent; no SR144528 antagonism was observed in either sex tested with CP55,940. Neither the time course of rimonabant antagonism nor the plasma levels of rimonabant differed between the sexes. Rimonabant and SR144528 did not antagonize morphine-induced antinociception, and naloxone did not antagonize THC-induced antinociception in either sex. These results suggest that THC produces acute antinociceptive and motoric effects via activation of CB1, and perhaps under some conditions, CB2 receptors, in female rats, whereas THC acts primarily at CB1 receptors in male rats. Higher apparent pKB for rimonabant in female rats suggests that cannabinoid drugs bind with greater affinity to CB1 receptors in female than male rats, probably contributing to greater antinociceptive effects observed in female compared with male rats.